Stockreport

AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]

AbCellera Biologics Inc. - Common Shares  (ABCL) 
PDF This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -21.4 [Read more]